Ciprofloxacin & Surgery: Timing Risks & Perioperative Management

Ciprofloxacin (a fluoroquinolone) requires careful perioperative timing due to specific risks. Always inform your surgical team of all current medications.

Why Fluoroquinolones Are Concerning Perioperatively

1. Tendon Rupture Risk
   • FDA Black Box Warning: increased tendinitis/rupture (especially Achilles).
   • Risk amplified by: age >60, corticosteroids, renal failure, diabetes, strenuous rehab.
   • Surgery itself stresses tendons (positioning, mobilization, bracing).
2. Drug Interactions
   • CYP1A2 inhibition → elevated levels of theophylline, clozapine, tizanidine, ropivacaine.
   • QT prolongation risk with anesthetic agents (propofol, volatile anesthetics), ondansetron, antibiotics.
   • Neuromuscular blockade potentiation (rare but reported).
3. Impaired Wound Healing
   • Animal and in vitro data: fluoroquinolones inhibit collagen synthesis, fibroblast proliferation, TGF-β signaling.
   • Clinical reports of delayed closure, dehiscence, anastomotic leak.

Perioperative Recommendations

• Elective surgery: Hold ciprofloxacin ≥48 hours pre-op (5 half-lives); restart post-op when wound stable, oral intake resumed, and no interacting drugs.
• Urgent/emergent surgery: Anesthesiology/surgery/ID consensus on risk-benefit; consider alternative antibiotic if infection prophylaxis needed.
• Document: Indication, last dose, renal function, interacting meds.

Individualized decision-making with your surgeon, anesthesiologist, and infectious disease consultant (if available) optimizes safety.